Digestive & Intestinal Remedies (Pharmacies) - Switzerland

Revenue in the Digestives & Intestinal Remedies market is projected to reach US$26.29m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.79%, resulting in a market volume of US$28.72m by 2029.
In global comparison, most revenue will be generated China (US$3.37bn in 2024).
In relation to total population figures, per person revenues of US$2.97 are generated in 2024.

Definition:
The Digestives and Intestinal Remedies market encompasses a range of over-the-counter (OTC) natural and synthetic digestive agents and remedies designed to address gastrointestinal concerns. These products are available through pharmacies and are provided in various forms such as pills, powder, capsules, liquids, solutions, suspensions, drops, and suppositories. The market excludes prescription medications, substances contravening state regulations, or items not explicitly categorized as digestive medications (e.g., pain relievers). Notable among the best-selling products in this category are Perenterol, Iberogast, Dulcolax, and Buscopan Plus. This market exclusively covers product sales through pharmacies.

Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Digestive medicines
Remedies against gastrointestinal complaints

Prescription medicines
Homeopathic remedies
Tea

The Digestive & Intestinal Remedies (Pharmacies) market in Switzerland has been experiencing steady growth in recent years.

Customer preferences: Swiss consumers have shown a growing interest in digestive and intestinal remedies, seeking products that can provide relief from common gastrointestinal issues such as indigestion, bloating, and constipation. This can be attributed to several factors, including the increasing prevalence of sedentary lifestyles and unhealthy eating habits. Additionally, the aging population in Switzerland has also contributed to the rising demand for digestive and intestinal remedies, as older individuals are more susceptible to digestive disorders.

Trends in the market: One notable trend in the Digestive & Intestinal Remedies market in Switzerland is the growing popularity of natural and herbal remedies. Consumers are becoming more conscious of the potential side effects of traditional pharmaceutical products and are seeking natural alternatives. This trend is reflected in the increasing availability of herbal digestive supplements and probiotics in Swiss pharmacies. Manufacturers have responded to this demand by developing innovative products that combine natural ingredients with scientific research, providing consumers with effective and safe solutions for their digestive health. Another trend in the market is the rising demand for over-the-counter (OTC) products. Swiss consumers prefer the convenience and accessibility of purchasing digestive and intestinal remedies directly from pharmacies without the need for a prescription. This trend has led to an expansion of the OTC segment in the market, with pharmacies offering a wide range of products to cater to the diverse needs of consumers. Pharmacies have also invested in knowledgeable staff who can provide expert advice and recommendations to customers, further enhancing the overall shopping experience.

Local special circumstances: Switzerland's strong healthcare infrastructure and high-quality standards contribute to the growth of the Digestive & Intestinal Remedies market. The country has a well-developed network of pharmacies that are easily accessible to consumers, ensuring that they have convenient access to a wide range of products. Additionally, the Swiss population has a high level of health consciousness, with individuals actively seeking preventive measures and remedies for their digestive health. This cultural emphasis on well-being and self-care has created a favorable environment for the growth of the market.

Underlying macroeconomic factors: The stable and prosperous economy of Switzerland has also played a role in the development of the Digestive & Intestinal Remedies market. The country has a high per capita income and a strong healthcare system, allowing consumers to afford and access the necessary remedies for their digestive health. Furthermore, the government's focus on healthcare and wellness promotion has encouraged individuals to prioritize their digestive health and seek appropriate remedies when needed. These macroeconomic factors have contributed to the sustained growth of the Digestive & Intestinal Remedies market in Switzerland.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.